Releases
ASLN
--
0.00%
--
  • All
  • Financials
  • Insiders
More
Webull provides the latest Aslan Pharms (ASLN) stock and general news. This information may help you make smarter investment decisions.
About ASLN
ASLAN Pharmaceuticals Limited (ASLAN) is a clinical-stage immunology and oncology-focused biopharmaceutical company. ASLAN has a clinical portfolio comprised of a first in class monoclonal therapy, ASLAN004, that is being developed in atopic dermatitis and other immunology indications, and a small molecule inhibitor targeting oncology.
More